# AbCellera Biologics Inc.: Form 8-K, filed Jul 6, 2022

- Company: [AbCellera Biologics Inc.](/companies/abcl.md) (CIK 1703057)
- Form: 8-K
- Filed: 2022-07-06
- Accepted by EDGAR: Jul 6, 2022, 16:57 ET
- Period: 2022-06-29
- Accession: 0001564590-22-025392
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1703057/000156459022025392/abcl-8k_20220629.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1703057/000156459022025392/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1703057/000156459022025392/abcl-8k_20220629.htm

Filed Jul 6, 2022.
Source: SEC EDGAR, the filing index for accession 0001564590-22-025392. Last ingested by Listed: Nov 15, 2026, 01:06 ET. No prices; not investment advice.
